Nuo Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-15.0M | $-52.8M | $-18.9M | $-20.2M | $-19.8M | $-3.5M | $-6.8M |
| Depreciation & Amortization | $1.1M | $741.0K | $613.5K | $1.1M | $1.2M | $631.2K | $440.2K |
| Depreciation | $262.0K | — | — | — | $823.0K | $364.0K | — |
| Amortization | $852.0K | — | — | — | — | — | — |
| Stock-Based Compensation | $53.5K | $782.8K | $1.3M | $717.9K | $2.0M | $305.2K | $411.0K |
| Net Cash from Operating Activities | $-4.9M | $-14.4M | $-17.4M | $-11.4M | $-11.4M | $-4.2M | $-3.5M |
| Investing Activities | |||||||
| Capital Expenditures | — | $698.2K | $483.0K | $750.7K | — | $66.4K | $774.6K |
| Business Acquisitions | — | — | — | $0 | $-24.6K | $0 | $2.0M |
| Net Cash from Investing Activities | $1.9K | — | — | — | $-1.6M | $22.8K | $-2.7M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | $471 | — | — | — | — | — | — |
| Net Cash from Financing Activities | $2.9M | — | — | — | $13.4M | $5.8M | $4.8M |
| Net Change in Cash | $-1.9M | $-15.0M | $12.7M | $670.9K | — | $1.6M | $-1.5M |
| Free Cash Flow | — | $-15.1M | $-17.9M | $-12.2M | — | $-4.3M | $-4.3M |